{"protocolSection": {"identificationModule": {"nctId": "NCT00943683", "orgStudyIdInfo": {"id": "0476-176"}, "secondaryIdInfos": [{"id": "MK0476-176"}, {"id": "2009_618"}], "organization": {"fullName": "Organon and Co", "class": "INDUSTRY"}, "briefTitle": "Montelukast in Pediatric Patients Aged 6 to 24 Months With Asthma--Safety Study (0476-176)", "officialTitle": "A Multicenter, Double-Blind, Randomized, Parallel-Group Study Comparing Montelukast With Placebo in Pediatric Patients Aged 6 to 24 Months With Asthma"}, "statusModule": {"statusVerifiedDate": "2022-02", "overallStatus": "COMPLETED", "expandedAccessInfo": {"hasExpandedAccess": false}, "startDateStruct": {"date": "2000-08"}, "primaryCompletionDateStruct": {"date": "2001-02", "type": "ACTUAL"}, "completionDateStruct": {"date": "2001-02", "type": "ACTUAL"}, "studyFirstSubmitDate": "2009-07-21", "studyFirstSubmitQcDate": "2009-07-21", "studyFirstPostDateStruct": {"date": "2009-07-22", "type": "ESTIMATED"}, "resultsFirstSubmitDate": "2009-07-27", "resultsFirstSubmitQcDate": "2010-05-18", "resultsFirstPostDateStruct": {"date": "2010-06-17", "type": "ESTIMATED"}, "lastUpdateSubmitDate": "2022-02-01", "lastUpdatePostDateStruct": {"date": "2022-02-03", "type": "ACTUAL"}}, "sponsorCollaboratorsModule": {"responsibleParty": {"type": "SPONSOR"}, "leadSponsor": {"name": "Organon and Co", "class": "INDUSTRY"}}, "descriptionModule": {"briefSummary": "A study of Montelukast compared to placebo in asthmatic children aged 6-24 months."}, "conditionsModule": {"conditions": ["Asthma"]}, "designModule": {"studyType": "INTERVENTIONAL", "phases": ["NA"], "designInfo": {"allocation": "RANDOMIZED", "interventionModel": "PARALLEL", "primaryPurpose": "TREATMENT", "maskingInfo": {"masking": "DOUBLE", "whoMasked": ["PARTICIPANT", "INVESTIGATOR"]}}, "enrollmentInfo": {"count": 256, "type": "ACTUAL"}}, "armsInterventionsModule": {"armGroups": [{"label": "1", "type": "EXPERIMENTAL", "description": "Montelukast", "interventionNames": ["Drug: montelukast sodium"]}, {"label": "2", "type": "PLACEBO_COMPARATOR", "description": "Placebo", "interventionNames": ["Drug: Comparator: Placebo"]}], "interventions": [{"type": "DRUG", "name": "montelukast sodium", "description": "Montelukast 4-mg oral granules mixed with applesauce once daily at bedtime for 6 weeks", "armGroupLabels": ["1"]}, {"type": "DRUG", "name": "Comparator: Placebo", "description": "Placebo oral granules mixed with applesauce once daily at bedtime for 6 weeks", "armGroupLabels": ["2"]}]}, "outcomesModule": {"primaryOutcomes": [{"measure": "Number of Clinical Adverse Experiences (CAEs) Reported by Patients During the 6-weeks of Treatment", "description": "An adverse experience (AE) is defined as any unfavorable and unintended change in the structure, function, or chemistry of the body temporally associated with the use of the SPONSOR'S product, whether or not considered related to the use of the product", "timeFrame": "During the 6 weeks of treatment"}]}, "eligibilityModule": {"eligibilityCriteria": "Inclusion Criteria:\n\n* Patient is in good, stable health\n* Patient has been fed solid foods for at least 1 month\n* Patients had at least 3 episodes of asthma or asthma-like symptoms, all occurring after 8 weeks of age; at least one within 6 months of the Prestudy Visit\n* Patients had to be in need of a controller therapy according to criteria established in the Global Initiative for Asthma (GINA) guidelines\n\nExclusion Criteria:\n\n* Patient was hospitalized at the start of the study or required a visit to the emergency room due to asthma with in past 2 weeks", "healthyVolunteers": false, "sex": "ALL", "minimumAge": "6 Months", "maximumAge": "24 Months", "stdAges": ["CHILD"]}, "contactsLocationsModule": {"overallOfficials": [{"name": "Medical Monitor", "affiliation": "Merck Sharp & Dohme LLC", "role": "STUDY_DIRECTOR"}]}, "referencesModule": {"references": [{"pmid": "15969897", "type": "RESULT", "citation": "van Adelsberg J, Moy J, Wei LX, Tozzi CA, Knorr B, Reiss TF. Safety, tolerability, and exploratory efficacy of montelukast in 6- to 24-month-old patients with asthma. Curr Med Res Opin. 2005 Jun;21(6):971-9. doi: 10.1185/030079905X48456."}]}}, "resultsSection": {"participantFlowModule": {"preAssignmentDetails": "Patients had at least 3 episodes of asthma or asthma-like symptoms, all occurring after 8 weeks of age; at least one within 6 months of the Prestudy Visit. Patients had to be in need of a controller therapy according to criteria established in the Global Initiative for Asthma (GINA) guidelines", "recruitmentDetails": "Patients were recruited at 65 study centers in Africa, Asia, Europe, North America, and South America Therapy period: Aug 2000 to Feb 2001", "groups": [{"id": "FG000", "title": "Placebo", "description": "Montelukast matching placebo oral granules mixed with applesauce once daily at bedtime for 6 weeks"}, {"id": "FG001", "title": "Montelukast", "description": "Montelukast 4-mg oral granules mixed with applesauce once daily at bedtime for 6 weeks"}], "periods": [{"title": "Overall Study", "milestones": [{"type": "STARTED", "achievements": [{"groupId": "FG000", "numSubjects": "81"}, {"groupId": "FG001", "numSubjects": "175"}]}, {"type": "COMPLETED", "achievements": [{"groupId": "FG000", "numSubjects": "74"}, {"groupId": "FG001", "numSubjects": "169"}]}, {"type": "NOT COMPLETED", "achievements": [{"groupId": "FG000", "numSubjects": "7"}, {"groupId": "FG001", "numSubjects": "6"}]}], "dropWithdraws": [{"type": "Adverse Event", "reasons": [{"groupId": "FG000", "numSubjects": "3"}, {"groupId": "FG001", "numSubjects": "3"}]}, {"type": "Lost to Follow-up", "reasons": [{"groupId": "FG000", "numSubjects": "1"}, {"groupId": "FG001", "numSubjects": "1"}]}, {"type": "Protocol Violation", "reasons": [{"groupId": "FG000", "numSubjects": "1"}, {"groupId": "FG001", "numSubjects": "2"}]}, {"type": "Withdrawal by Subject", "reasons": [{"groupId": "FG000", "numSubjects": "1"}, {"groupId": "FG001", "numSubjects": "0"}]}, {"type": "Patient Moved", "reasons": [{"groupId": "FG000", "numSubjects": "1"}, {"groupId": "FG001", "numSubjects": "0"}]}]}]}, "baselineCharacteristicsModule": {"groups": [{"id": "BG000", "title": "Placebo", "description": "Montelukast matching placebo oral granules mixed with applesauce once daily at bedtime for 6 weeks"}, {"id": "BG001", "title": "Montelukast", "description": "Montelukast 4-mg oral granules mixed with applesauce once daily at bedtime for 6 weeks"}, {"id": "BG002", "title": "Total", "description": "Total of all reporting groups"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "BG000", "value": "81"}, {"groupId": "BG001", "value": "175"}, {"groupId": "BG002", "value": "256"}]}], "measures": [{"title": "Age, Continuous", "paramType": "MEAN", "dispersionType": "STANDARD_DEVIATION", "unitOfMeasure": "Months", "classes": [{"categories": [{"measurements": [{"groupId": "BG000", "value": "14.05", "spread": "5.22"}, {"groupId": "BG001", "value": "14.90", "spread": "4.70"}, {"groupId": "BG002", "value": "14.63", "spread": "4.87"}]}]}]}, {"title": "Sex: Female, Male", "paramType": "COUNT_OF_PARTICIPANTS", "unitOfMeasure": "Participants", "classes": [{"categories": [{"title": "Female", "measurements": [{"groupId": "BG000", "value": "22"}, {"groupId": "BG001", "value": "59"}, {"groupId": "BG002", "value": "81"}]}, {"title": "Male", "measurements": [{"groupId": "BG000", "value": "59"}, {"groupId": "BG001", "value": "116"}, {"groupId": "BG002", "value": "175"}]}]}]}]}, "outcomeMeasuresModule": {"outcomeMeasures": [{"type": "PRIMARY", "title": "Number of Clinical Adverse Experiences (CAEs) Reported by Patients During the 6-weeks of Treatment", "description": "An adverse experience (AE) is defined as any unfavorable and unintended change in the structure, function, or chemistry of the body temporally associated with the use of the SPONSOR'S product, whether or not considered related to the use of the product", "populationDescription": "All patients who took study medication were included in the analysis.", "reportingStatus": "POSTED", "paramType": "NUMBER", "unitOfMeasure": "Participants", "timeFrame": "During the 6 weeks of treatment", "groups": [{"id": "OG000", "title": "Placebo", "description": "Montelukast matching placebo oral granules mixed with applesauce once daily at bedtime for 6 weeks"}, {"id": "OG001", "title": "Montelukast", "description": "Montelukast 4-mg oral granules mixed with applesauce once daily at bedtime for 6 weeks"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "81"}, {"groupId": "OG001", "value": "175"}]}], "classes": [{"title": "With CAEs", "categories": [{"measurements": [{"groupId": "OG000", "value": "62"}, {"groupId": "OG001", "value": "132"}]}]}, {"title": "Without CAEs", "categories": [{"measurements": [{"groupId": "OG000", "value": "19"}, {"groupId": "OG001", "value": "43"}]}]}]}]}, "adverseEventsModule": {"frequencyThreshold": "5", "timeFrame": "During the 6 weeks of treatment and including 14 days following treatment", "eventGroups": [{"id": "EG000", "title": "Placebo", "description": "Montelukast matching placebo oral granules mixed with applesauce once daily at bedtime for 6 weeks", "seriousNumAffected": 1, "seriousNumAtRisk": 81, "otherNumAffected": 55, "otherNumAtRisk": 81}, {"id": "EG001", "title": "Montelukast", "description": "Montelukast 4-mg oral granules mixed with applesauce once daily at bedtime for 6 weeks", "seriousNumAffected": 7, "seriousNumAtRisk": 175, "otherNumAffected": 112, "otherNumAtRisk": 175}], "seriousEvents": [{"term": "Dehydration", "organSystem": "Metabolism and nutrition disorders", "sourceVocabulary": "CRISP dictionaries", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 81}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 175}]}, {"term": "Drug Overdose", "organSystem": "Injury, poisoning and procedural complications", "sourceVocabulary": "CRISP dictionaries", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 81}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 175}]}, {"term": "Inguinal Hernia", "organSystem": "Musculoskeletal and connective tissue disorders", "sourceVocabulary": "CRISP dictionaries", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 81}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 175}]}, {"term": "Diarrhea", "organSystem": "Gastrointestinal disorders", "sourceVocabulary": "CRISP dictionaries", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 81}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 175}]}, {"term": "Aspiration (Condition)", "organSystem": "Respiratory, thoracic and mediastinal disorders", "sourceVocabulary": "CRISP dictionaries", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 81}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 175}]}, {"term": "Asthma", "organSystem": "Respiratory, thoracic and mediastinal disorders", "sourceVocabulary": "CRISP dictionaries", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 81}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 175}]}, {"term": "Bronchiolitis", "organSystem": "Respiratory, thoracic and mediastinal disorders", "sourceVocabulary": "CRISP dictionaries", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 1, "numAtRisk": 81}, {"groupId": "EG001", "numAffected": 0, "numAtRisk": 175}]}, {"term": "Pneumonia", "organSystem": "Infections and infestations", "sourceVocabulary": "CRISP dictionaries", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 81}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 175}]}, {"term": "Urinary Tract Infection", "organSystem": "Infections and infestations", "sourceVocabulary": "CRISP dictionaries", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 0, "numAtRisk": 81}, {"groupId": "EG001", "numAffected": 1, "numAtRisk": 175}]}], "otherEvents": [{"term": "Fever", "organSystem": "General disorders", "sourceVocabulary": "CRISP dictionaries", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 11, "numAtRisk": 81}, {"groupId": "EG001", "numAffected": 23, "numAtRisk": 175}]}, {"term": "Upper Respiratory Infection", "organSystem": "Infections and infestations", "sourceVocabulary": "CRISP dictionaries", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 17, "numAtRisk": 81}, {"groupId": "EG001", "numAffected": 56, "numAtRisk": 175}]}, {"term": "Diarrhea", "organSystem": "Gastrointestinal disorders", "sourceVocabulary": "CRISP dictionaries", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 10, "numAtRisk": 81}, {"groupId": "EG001", "numAffected": 18, "numAtRisk": 175}]}, {"term": "Vomiting", "organSystem": "Gastrointestinal disorders", "sourceVocabulary": "CRISP dictionaries", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 9, "numAtRisk": 81}, {"groupId": "EG001", "numAffected": 15, "numAtRisk": 175}]}, {"term": "Conjunctivitis", "organSystem": "Eye disorders", "sourceVocabulary": "CRISP dictionaries", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 5, "numAtRisk": 81}, {"groupId": "EG001", "numAffected": 4, "numAtRisk": 175}]}, {"term": "Otitis Media", "organSystem": "Ear and labyrinth disorders", "sourceVocabulary": "CRISP dictionaries", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 5, "numAtRisk": 81}, {"groupId": "EG001", "numAffected": 15, "numAtRisk": 175}]}, {"term": "Pharyngitis", "organSystem": "Respiratory, thoracic and mediastinal disorders", "sourceVocabulary": "CRISP dictionaries", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 6, "numAtRisk": 81}, {"groupId": "EG001", "numAffected": 14, "numAtRisk": 175}]}, {"term": "Asthma", "organSystem": "Respiratory, thoracic and mediastinal disorders", "sourceVocabulary": "CRISP dictionaries", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 18, "numAtRisk": 81}, {"groupId": "EG001", "numAffected": 32, "numAtRisk": 175}]}, {"term": "Bronchitis", "organSystem": "Respiratory, thoracic and mediastinal disorders", "sourceVocabulary": "CRISP dictionaries", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 5, "numAtRisk": 81}, {"groupId": "EG001", "numAffected": 7, "numAtRisk": 175}]}, {"term": "Rash", "organSystem": "Skin and subcutaneous tissue disorders", "sourceVocabulary": "CRISP dictionaries", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numAffected": 5, "numAtRisk": 81}, {"groupId": "EG001", "numAffected": 9, "numAtRisk": 175}]}]}, "moreInfoModule": {"certainAgreement": {"piSponsorEmployee": false, "restrictionType": "OTHER", "restrictiveAgreement": true, "otherDetails": "Merck agreements may vary with individual investigators, but will not prohibit any investigator from publishing. Merck supports the publication of results from all centers of a multi-center trial but requests that reports based on single-site data not precede the primary publication of the entire clinical trial."}, "pointOfContact": {"title": "Senior Vice President, Global Clinical Development", "organization": "Merck Sharp & Dohme Corp", "phone": "1-800-672-6372"}}}, "derivedSection": {"miscInfoModule": {"versionHolder": "2024-06-24"}, "conditionBrowseModule": {"meshes": [{"id": "D000001249", "term": "Asthma"}], "ancestors": [{"id": "D000001982", "term": "Bronchial Diseases"}, {"id": "D000012140", "term": "Respiratory Tract Diseases"}, {"id": "D000008173", "term": "Lung Diseases, Obstructive"}, {"id": "D000008171", "term": "Lung Diseases"}, {"id": "D000012130", "term": "Respiratory Hypersensitivity"}, {"id": "D000006969", "term": "Hypersensitivity, Immediate"}, {"id": "D000006967", "term": "Hypersensitivity"}, {"id": "D000007154", "term": "Immune System Diseases"}], "browseLeaves": [{"id": "M4556", "name": "Asthma", "asFound": "Asthma", "relevance": "HIGH"}, {"id": "M5258", "name": "Bronchial Diseases", "relevance": "LOW"}, {"id": "M14977", "name": "Respiratory Tract Diseases", "relevance": "LOW"}, {"id": "M11168", "name": "Lung Diseases", "relevance": "LOW"}, {"id": "M11170", "name": "Lung Diseases, Obstructive", "relevance": "LOW"}, {"id": "M10018", "name": "Hypersensitivity", "relevance": "LOW"}, {"id": "M14967", "name": "Respiratory Hypersensitivity", "relevance": "LOW"}, {"id": "M10020", "name": "Hypersensitivity, Immediate", "relevance": "LOW"}, {"id": "M10200", "name": "Immune System Diseases", "relevance": "LOW"}], "browseBranches": [{"abbrev": "BC08", "name": "Respiratory Tract (Lung and Bronchial) Diseases"}, {"abbrev": "BC20", "name": "Immune System Diseases"}, {"abbrev": "All", "name": "All Conditions"}]}, "interventionBrowseModule": {"meshes": [{"id": "C000093875", "term": "Montelukast"}], "ancestors": [{"id": "D000018927", "term": "Anti-Asthmatic Agents"}, {"id": "D000019141", "term": "Respiratory System Agents"}, {"id": "D000020024", "term": "Leukotriene Antagonists"}, {"id": "D000006727", "term": "Hormone Antagonists"}, {"id": "D000006730", "term": "Hormones, Hormone Substitutes, and Hormone Antagonists"}, {"id": "D000045505", "term": "Physiological Effects of Drugs"}, {"id": "D000065694", "term": "Cytochrome P-450 CYP1A2 Inducers"}, {"id": "D000065693", "term": "Cytochrome P-450 Enzyme Inducers"}, {"id": "D000045504", "term": "Molecular Mechanisms of Pharmacological Action"}], "browseLeaves": [{"id": "M274108", "name": "Montelukast", "asFound": "Conduction", "relevance": "HIGH"}, {"id": "M20963", "name": "Anti-Asthmatic Agents", "relevance": "LOW"}, {"id": "M21137", "name": "Respiratory System Agents", "relevance": "LOW"}, {"id": "M21876", "name": "Leukotriene Antagonists", "relevance": "LOW"}, {"id": "M9789", "name": "Hormones", "relevance": "LOW"}, {"id": "M9788", "name": "Hormone Antagonists", "relevance": "LOW"}], "browseBranches": [{"abbrev": "Resp", "name": "Respiratory System Agents"}, {"abbrev": "All", "name": "All Drugs and Chemicals"}]}}, "hasResults": true}